Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a comprehensive list of Locations covering the United States, Canada, Australia, and Europe; removed the prior location blocks and the HHS Vulnerability Disclosure entry.
    Difference
    2%
    Check dated 2025-12-23T17:22:49.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publication note updated to indicate PubMed-derived publications are automatically filled and may not be about the study, and the revision tag changed to v3.3.2 (from v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-24T21:27:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the generic government funding/operating status notice from the page. This deletion does not affect the trial content or user actions.
    Difference
    0.1%
    Check dated 2025-11-17T19:22:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    No significant changes were detected in the study record between the screenshots; the core content (title, conditions, interventions, eligibility criteria, outcomes, and locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T13:43:50.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Important updates include a notice about government funding impacts and operating status, plus a new version (v3.2.0); the old version tag (v3.1.0) was removed. If no other major content changes are present, this represents an operational update rather than a broad content overhaul.
    Difference
    2%
    Check dated 2025-10-06T04:23:20.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Core terminology updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and the document/page version bumped to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T23:38:52.000Z thumbnail image

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.